Relationship Between Arterial Calcification and Bone Loss in a New Combined Model Rat by Ovariectomy and Vitamin D3 Plus Nicotine by Park Jong-Hoon et al.
Relationship Between Arterial Calcification
and Bone Loss in a New Combined Model Rat by
Ovariectomy and Vitamin D3 Plus Nicotine
著者 Park Jong-Hoon, Omi Naomi, Iemitsu Motoyuki,









権利 (C) Springer Science+Business Media, LLC 2008
URL http://hdl.handle.net/2241/104451
doi: 10.1007/s00223-008-9162-1
   1 
Figure legends 
 
Figure 1. The calcium content, calcification, and elastic fiber network in the medial 
layer of aorta tissue. A: the arterial tissue calcium content in Sham-operated rats at 4 and 
8 weeks after Control treatment (4SC and 8SC), Ovariectomized rats at 4 and 8 weeks 
after Control treatment (4OC and 8OC), Ovariectomized rats at 4 and 8 weeks after 
Vitamin D3 and Nicotine treatment (4OVN and 8OVN). B: von Kossa staining, 
showing linear and scattered aggregates of calcification (see arrows) among the elastic 
fibers of the aortas of 8SC, 8OC, and 8OVN. elastica van Gieson staining, exhibiting 
drastic disassociation and fragmentation of elastic fiber network (see triangles) in the 
medial layer of the aortas of 8SC, 8OC, and 8OVN (original magnification 40×). Values 
are expressed mean ± SE.  
 
Figure 2. The associations between arterial calcium content and indexes of bone loss, 
i.e., BMD of the tibial proximal metaphysis, femoral breaking force, and dry weight and 
ash weight of the femur, in sham-operated rats at 8 weeks after control treatment and 
ovariectomized rats at 8 weeks after Vitamin D3 and Nicotine treatment.  
 
Figure 3. The endothelin-1 (ET-1) levels in the aortas of Sham-operated rats at 4 and 8 
weeks after Control treatment (4SC and 8SC), Ovariectomized rats at 4 and 8 weeks 
after Control treatment (4OC and 8OC), Ovariectomized rats at 4 and 8 weeks after 
Vitamin D3 and Nicotine treatment (4OVN and 8OVN) (A). The relationship between 
arterial ET-1 level and calcium content in 8SC and 8OVN (B). Values are expressed 
mean ± SE. 
 
   2 
Figure 4. The endothelial nitric oxide synthase (eNOS) protein in aortas of 
Sham-operated rats at 4 and 8 weeks after Control treatment (4SC and 8SC), 
Ovariectomized rats at 4 and 8 weeks after Control treatment (4OC and 8OC), 
Ovariectomized rats at 4 and 8 weeks after Vitamin D3 and Nicotine treatment (4OVN 
and 8OVN). Above, typical examples of Western blotting analysis. The arrow indicates 
the Immunoblot band for eNOS protein (135kDa). Values are expressed mean ± SE. 
 
Figure 5. The typical examples of the expression of estrogen receptor α, β proteins in 
the aortas of Sham-operated rats at 4 and 8 weeks after Control treatment (4SC and 
8SC), Ovariectomized rats at 4 and 8 weeks after Control treatment (4OC and 8OC), 
Ovariectomized rats at 4 and 8 weeks after Vitamin D3 and Nicotine treatment (4OVN 
and 8OVN) by Western blot. The arrow indicates the Immunoblot band for estrogen 
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Estrogen α receptor protein
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Table 1. Plasma calcium and estradiol concentrations 
Data show means ± SE. Sham-operated rats at 4 and 8 weeks after Cont-
rol treatment (4SC and 8SC); Ovariectomized rats at 4 and 8 weeks after 
Control treatment (4OC and 8OC); Ovariectomized rats at 4 and 8 weeks 
after Vitamin D3 and Nicotine treatment (4OVN and 8OVN). * p < 0.001, 
vs. the other groups.
11.09  ± 0.43 18.08  ± 0.44
11.18  ± 0.27
11.89  ± 0.35
Calcium Estradiol
(mg/dl) (pg/ml)
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Table 2.  BMD of tibia and dry weight, ash weight, and mechanical test  of femur  
Tibia Femur
BMD of  proximal metaphysis dry weight ash weight breaking force
(mg/cm2) (g/100g B.W.) (g/100g B.W.) (×106 dyn / 100g B.W.)
4SC 158.90 ± 7.82 0.185 ± 0.003 0.121 ± 0.004 7.360 ± 0.43
4OC 150.84 ± 2.80 0.154 ± 0.004 0.095 ± 0.002 6.806 ± 0.27
4OVN 134.94 ± 2.65 0.148 ± 0.003 0.092 ± 0.002 5.970 ± 0.20
8SC 187.94 ± 4.38 0.193 ± 0.002 0.128 ± 0.002 7.630 ± 0.35
8OC 156.19 ± 2.52 0.164 ± 0.002 0.104 ± 0.001 6.547 ± 0.117
8OVN 154.85 ± 4.63 0.169 ± 0.002 0.101 ± 0.002 6.262 ± 0.143
Data show means ± SE. Sham-operated rats at 4 and 8 weeks after Control treatment (4SC and 
8SC); Ovariectomized rats at 4 and 8 weeks after Control treatment (4OC and 8OC); Ovariecto-
mized rats at 4 and 8 weeks after Vitamin D3 and Nicotine treatment (4OVN and 8OVN). ** p < 
0.01, *** p < 0.001 vs SC, † p < 0.05 vs OC.
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